간행물

생화학분자생물학회입니다.


EMM

Curing the brain: in search for new astrocyte-specific therapies

  • 작성자

    Changjoon Justin Lee
  • 작성일자

    2026-07-24
  • 조회수

    447
Changjoon Justin Lee Changjoon Justin Lee (cjl@ibs.re.kr)
2018-present Director, Center for Memory and Glioscience (formerly Center for Cognition and Sociality), Institute for Basic Science (IBS), South Korea
2022-2024 Director General, Life Science Institute, Institute for Basic Science (IBS), South Korea
2004-2018 Research Scientist, Korea Institute of Science and Technology (KIST), South Korea
2001-2004 Post Doctoral Fellow, Department of Pharmacology, Emory University, Atlanta, GA, USA
1991-2000 PhD, Department of Physiology and Cellular Biophysics, Columbia University, New York, USA
1985-1990 BA in Chemistry, The University of Chicago, Chicago, IL, USA

Curing the brain: in search for new astrocyte-specific therapies

Astroglia, an extended class of homeostatic and defensive cells of the central nervous system (CNS), contribute to the pathogenesis of all known neurological and neuropsychiatric disorders. The pathophysiology of astrocytes is complex, mutable, disease and disease-stage specific. In neuroinflammatory lesions and in various chronic conditions, astrocytes undergo an evolutionary conserved defensive remodeling known as reactive astrogliosis, which produces highly heterogeneous reactive astrocytic phenotypes. Broadly, reactive astrogliosis can be classified into proliferative anysomorphic barrier-forming astrogliosis characteristic of traumatic CNS lesions and nonproliferative isomorphic gliosis widely manifested in chronic neuropathologies. In addition, in many pathologies, astrocytes undergo atrophy and asthenia with resulting loss of homeostatic support and neuroprotection precipitating neuronal damage. Reactive and atrophic astrocytes may coexist or emerge in sequence in a disease-stage-dependent manner. Several classes of astrocyte-specific molecules and processes implicated in various diseases of the CNS represent therapeutic targets. Astrocyte-specific therapeutic strategies may improve both disease-preventing and disease-modifying therapeutic outcomes.

Exp Mol Med. 2026 Apr;58(4):1086-1127. doi: 10.1038/s12276-026-01712-4.
https://pubmed.ncbi.nlm.nih.gov/4203220